These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36469363)

  • 1. Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor-Positive Breast Cancer.
    Wei L; Gao H; Yu J; Zhang H; Nguyen TTL; Gu Y; Passow MR; Carter JM; Qin B; Boughey JC; Goetz MP; Weinshilboum RM; Ingle JN; Wang L
    Cancer Res; 2023 Feb; 83(3):456-470. PubMed ID: 36469363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Androgen Receptor Modulator RAD140 Inhibits the Growth of Androgen/Estrogen Receptor-Positive Breast Cancer Models with a Distinct Mechanism of Action.
    Yu Z; He S; Wang D; Patel HK; Miller CP; Brown JL; Hattersley G; Saeh JC
    Clin Cancer Res; 2017 Dec; 23(24):7608-7620. PubMed ID: 28974548
    [No Abstract]   [Full Text] [Related]  

  • 3. Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer.
    Ciupek A; Rechoum Y; Gu G; Gelsomino L; Beyer AR; Brusco L; Covington KR; Tsimelzon A; Fuqua SA
    Breast Cancer Res Treat; 2015 Nov; 154(2):225-37. PubMed ID: 26487496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.
    Cochrane DR; Bernales S; Jacobsen BM; Cittelly DM; Howe EN; D'Amato NC; Spoelstra NS; Edgerton SM; Jean A; Guerrero J; Gómez F; Medicherla S; Alfaro IE; McCullagh E; Jedlicka P; Torkko KC; Thor AD; Elias AD; Protter AA; Richer JK
    Breast Cancer Res; 2014 Jan; 16(1):R7. PubMed ID: 24451109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor-mediated pharmacogenomic expression quantitative trait loci: implications for breast cancer response to AR-targeting therapy.
    Gao H; Wei L; Indulkar S; Nguyen TTL; Liu D; Ho MF; Zhang C; Li H; Weinshilboum RM; Ingle JN; Wang L
    Breast Cancer Res; 2024 Jul; 26(1):111. PubMed ID: 38965614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen Receptor Expression and Bicalutamide Antagonize Androgen Receptor Inhibit β-Catenin Transcription Complex in Estrogen Receptor-Negative Breast Cancer.
    Huang R; Han J; Liang X; Sun S; Jiang Y; Xia B; Niu M; Li D; Zhang J; Wang S; Wei W; Liu Q; Zheng W; Zhang G; Song Y; Panga D
    Cell Physiol Biochem; 2017; 43(6):2212-2225. PubMed ID: 29069648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer.
    Hickey TE; Selth LA; Chia KM; Laven-Law G; Milioli HH; Roden D; Jindal S; Hui M; Finlay-Schultz J; Ebrahimie E; Birrell SN; Stelloo S; Iggo R; Alexandrou S; Caldon CE; Abdel-Fatah TM; Ellis IO; Zwart W; Palmieri C; Sartorius CA; Swarbrick A; Lim E; Carroll JS; Tilley WD
    Nat Med; 2021 Feb; 27(2):310-320. PubMed ID: 33462444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation.
    Garay JP; Karakas B; Abukhdeir AM; Cosgrove DP; Gustin JP; Higgins MJ; Konishi H; Konishi Y; Lauring J; Mohseni M; Wang GM; Jelovac D; Weeraratna A; Sherman Baust CA; Morin PJ; Toubaji A; Meeker A; De Marzo AM; Lewis G; Subhawong A; Argani P; Park BH
    Breast Cancer Res; 2012 Feb; 14(1):R27. PubMed ID: 22321971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative Dynamics of AR and ER Activity in Breast Cancer.
    D'Amato NC; Gordon MA; Babbs B; Spoelstra NS; Carson Butterfield KT; Torkko KC; Phan VT; Barton VN; Rogers TJ; Sartorius CA; Elias A; Gertz J; Jacobsen BM; Richer JK
    Mol Cancer Res; 2016 Nov; 14(11):1054-1067. PubMed ID: 27565181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting androgen receptor in estrogen receptor-negative breast cancer.
    Ni M; Chen Y; Lim E; Wimberly H; Bailey ST; Imai Y; Rimm DL; Liu XS; Brown M
    Cancer Cell; 2011 Jul; 20(1):119-31. PubMed ID: 21741601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells.
    Need EF; Selth LA; Harris TJ; Birrell SN; Tilley WD; Buchanan G
    Mol Endocrinol; 2012 Nov; 26(11):1941-52. PubMed ID: 23023562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor and estrogen receptor variants in prostate and breast cancers.
    Valentín López JC; Lange CA; Dehm SM
    J Steroid Biochem Mol Biol; 2024 Jul; 241():106522. PubMed ID: 38641298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines.
    Rizza P; Barone I; Zito D; Giordano F; Lanzino M; De Amicis F; Mauro L; Sisci D; Catalano S; Dahlman Wright K; Gustafsson JA; Andò S
    Breast Cancer Res; 2014 Feb; 16(1):R21. PubMed ID: 24552459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
    De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
    BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential clinical benefit of targeting androgen receptor (AR) in estrogen-receptor positive breast cancer cells treated with Exemestane.
    Amaral C; Augusto TV; Almada M; Cunha SC; Correia-da-Silva G; Teixeira N
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165661. PubMed ID: 31891807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AR collaborates with ERα in aromatase inhibitor-resistant breast cancer.
    Rechoum Y; Rovito D; Iacopetta D; Barone I; Andò S; Weigel NL; O'Malley BW; Brown PH; Fuqua SA
    Breast Cancer Res Treat; 2014 Oct; 147(3):473-85. PubMed ID: 25178514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating the Activity of Androgen Receptor for Treating Breast Cancer.
    You CP; Tsoi H; Man EPS; Leung MH; Khoo US
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.
    Hu DG; Selth LA; Tarulli GA; Meech R; Wijayakumara D; Chanawong A; Russell R; Caldas C; Robinson JL; Carroll JS; Tilley WD; Mackenzie PI; Hickey TE
    Cancer Res; 2016 Oct; 76(19):5881-5893. PubMed ID: 27496708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.
    Mafuvadze B; Liang Y; Hyder SM
    Oncol Rep; 2014 Oct; 32(4):1727-33. PubMed ID: 25051231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting Androgen Receptor Signaling in Breast Cancer.
    Dai C; Ellisen LW
    Oncologist; 2023 May; 28(5):383-391. PubMed ID: 36972361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.